APR 20, 2022 2:10 PM PDT

Rare Soil Microbe Shows Promise as New Antibiotic

WRITTEN BY: Annie Lennon

 

Antibiotic resistance has increased the demand for new antibiotic treatments. Now, researchers have found that a soil bacterium holds potential for the development of a new antibiotic. The corresponding study was published in PNAS.

Actinomycetes are gram-positive bacteria that produce bioactive components used in a variety of drugs from antibiotics to anti-cancer agents. In fact, around two-thirds of all antibiotics used in hospital settings and clinics are derived at least in part from actinomycetes. 

Whereas many have been extensively studied, some known as ‘rare’ actinomycetes have been cataloged but not extensively researched. These bacteria are considered ‘rare’ as they tend to be less common in nature than others. 

In the present study, researchers set out to characterize some of these rare actinomycetes for drug delivery and biotechnology purposes. In doing so, they found that Lentzea flaviverrucosa, a microbe found in soil, produces molecules that are active against specific varieties of ovarian cancer, fibrosarcoma and prostate cancer, and leukemia cell lines. 

"At a high level, it looked as if one region of the genome might be able to make two different molecules. That's just a little strange," said Joshua Blodgett, assistant professor of biology at Washington University in St. Louis, co-corresponding author of the new study. 

"Usually we think of a gene cluster, groups of genes that are like blueprints for making individual drug-like molecules. But it looked like there was almost too much chemistry predicted within this single cluster," he added.

From a combination of modern metabolomics with chemical and structural biology techniques, the researchers saw that one region of the bacteria's genome was able to produce two different bioactive molecules. These molecules, they found, are then later welded together to create a potent chemical reaction. 

"Nature is welding two different things together. And, as it turns out, against several different cancer cell lines, when you stick A and B together, it turns into something more potent,” concluded Dr. Blodgett. 

 

Sources: PNASScience Daily

About the Author
University College London
Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
APR 20, 2022
Cancer
"Saturating" the Liver with Chemotherapy to Treat Cancer
APR 20, 2022
"Saturating" the Liver with Chemotherapy to Treat Cancer
Uveal melanoma is a rare type of cancer that grows in the melanin, the dark-colored pigment of the eye. About  ...
APR 22, 2022
Immunology
How Diet Affects Your Immune System
APR 22, 2022
How Diet Affects Your Immune System
Our immune system plays a vital role in our bodies, as it is literally responsible for keeping us healthy and free of ha ...
APR 28, 2022
Immunology
Lipid Supplement May Reduce Inflammation in MS
APR 28, 2022
Lipid Supplement May Reduce Inflammation in MS
Administration of an inflammation-mediating lipid has shown promise in reducing multiple sclerosis-related inflammation ...
JUN 06, 2022
Clinical & Molecular DX
Researchers Confirm the Impact of Gut Viruses on Inflammatory Bowel Disease
JUN 06, 2022
Researchers Confirm the Impact of Gut Viruses on Inflammatory Bowel Disease
The gut microbiome refers to the collection of microorganisms that reside within the gut. The gut microbiome is known to ...
JUN 10, 2022
Drug Discovery & Development
The consequences of inappropriate antibiotic prescriptions in children
JUN 10, 2022
The consequences of inappropriate antibiotic prescriptions in children
The discovery of antibiotics in the early 1900’s was one of the most important discoveries in medical history. The ...
JUN 23, 2022
Clinical & Molecular DX
Accelerate diagnostic development with the right supplier
JUN 23, 2022
Accelerate diagnostic development with the right supplier
Diagnostic assays like the one you’re developing are in demand. But your task isn’t simple. Set yourself up ...
Loading Comments...